Skip to search formSkip to main contentSkip to account menu

alizapride

Known as: N-((1-Allyl-2-Pyrrolidinyl)Methyl)-6-Methoxy-1H-Benzotriazole-5-Carboxamide, Alizaprida, Alizapridum 
A substituted benzamide that acts as a dopamine receptor antagonist with antiemetic properties.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2013
Review
2013
Background Older patients are at high risk for experiencing Adverse Drug Events (ADEs) during hospitalization. To be able to… 
Highly Cited
2006
Highly Cited
2006
BACKGROUND We have compared the use of alizapride, propofol, droperidol and promethazine for the prevention of spinal morphine… 
Review
2003
Review
2003
It is commonly claimed that the nausea and vomiting accompanying cytotoxic chemotherapy have a negative impact on health-related… 
Review
2001
Review
2001
Abstract Objective: To quantify the antiemetic efficacy and adverse effects of cannabis used for sickness induced by chemotherapy… 
Review
1994
Review
1994
Granisetron is a selective serotonin3 (5-hydroxytryptamine3, 5-HT3) receptor antagonist which has significant antiemetic activity… 
Highly Cited
1986
Highly Cited
1986
Women (182) undergoing elective orthopaedic surgery under general anaesthesia received 100 or 200 mg alizapride, 1.25 mg…